DK1609863T3 - Udskilte polypeptider og transmembranpolypeptider samt nucleinsyrer kodende for disse - Google Patents

Udskilte polypeptider og transmembranpolypeptider samt nucleinsyrer kodende for disse

Info

Publication number
DK1609863T3
DK1609863T3 DK05014619T DK05014619T DK1609863T3 DK 1609863 T3 DK1609863 T3 DK 1609863T3 DK 05014619 T DK05014619 T DK 05014619T DK 05014619 T DK05014619 T DK 05014619T DK 1609863 T3 DK1609863 T3 DK 1609863T3
Authority
DK
Denmark
Prior art keywords
polypeptides
well
present
nucleic acids
acids encoding
Prior art date
Application number
DK05014619T
Other languages
Danish (da)
English (en)
Inventor
Luc Desnoyers
Dan L Eaton
Audrey Goddard
Paul J Godowski
Timothy A Stewart
Colin K Watanabe
William I Wood
Zemin Zhang
Austin L Gurney
James Pan
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK1609863T3 publication Critical patent/DK1609863T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
DK05014619T 1999-03-23 2000-03-01 Udskilte polypeptider og transmembranpolypeptider samt nucleinsyrer kodende for disse DK1609863T3 (da)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US12577899P 1999-03-23 1999-03-23
US12577499P 1999-03-23 1999-03-23
US12582699P 1999-03-24 1999-03-24
US12703599P 1999-03-31 1999-03-31
US12770699P 1999-04-05 1999-04-05
US13035999P 1999-04-21 1999-04-21
US13127299P 1999-04-27 1999-04-27
US13127099P 1999-04-27 1999-04-27
US13129199P 1999-04-27 1999-04-27
US13237199P 1999-05-04 1999-05-04
US13237999P 1999-05-04 1999-05-04
US13238399P 1999-05-04 1999-05-04
US13575099P 1999-05-25 1999-05-25
US13816699P 1999-06-08 1999-06-08
US14479199P 1999-07-20 1999-07-20
US14697099P 1999-08-03 1999-08-03
US17026299P 1999-12-09 1999-12-09
PCT/US2000/005601 WO2000056889A2 (fr) 1999-03-23 2000-03-01 Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci

Publications (1)

Publication Number Publication Date
DK1609863T3 true DK1609863T3 (da) 2008-12-15

Family

ID=27586019

Family Applications (3)

Application Number Title Priority Date Filing Date
DK05011885T DK1616878T3 (da) 1999-03-23 2000-03-01 Udskilte og membranspændende polypeptider samt nukleinsyrer kodende for disse
DK05014619T DK1609863T3 (da) 1999-03-23 2000-03-01 Udskilte polypeptider og transmembranpolypeptider samt nucleinsyrer kodende for disse
DK00917717T DK1169442T3 (da) 1999-03-23 2000-03-01 Secernerede polypeptider og transmembran-polypeptider og nukleinsyrer, der koder for disse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK05011885T DK1616878T3 (da) 1999-03-23 2000-03-01 Udskilte og membranspændende polypeptider samt nukleinsyrer kodende for disse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK00917717T DK1169442T3 (da) 1999-03-23 2000-03-01 Secernerede polypeptider og transmembran-polypeptider og nukleinsyrer, der koder for disse

Country Status (11)

Country Link
EP (4) EP1688430B1 (fr)
JP (8) JP4174183B2 (fr)
KR (1) KR100504305B1 (fr)
AT (4) ATE329023T1 (fr)
AU (1) AU764092B2 (fr)
CA (1) CA2361221A1 (fr)
DK (3) DK1616878T3 (fr)
ES (3) ES2314521T3 (fr)
NZ (3) NZ527293A (fr)
PT (3) PT1616878E (fr)
WO (1) WO2000056889A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
US20020192751A1 (en) 1998-05-15 2002-12-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2354027A1 (fr) * 1998-12-23 2000-07-06 Genentech, Inc. Polypeptides apparentes a il-1
DK1992695T3 (da) * 1999-08-12 2011-02-14 Agensys Inc Lectin-transmembran-antigen af type C udtrykt i human prostatacancer og avendelser deraf
US7842458B2 (en) 1999-08-12 2010-11-30 Agensys, Inc. Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
MXPA02007674A (es) * 2000-02-08 2002-12-13 Amgen Inc Moleculas similares a interlucina-17 y uso de las mismas.
EP1260584A4 (fr) * 2000-02-15 2004-05-19 Chugai Pharmaceutical Co Ltd Nouvelle proteine comportant une sequence signal
AU2001233957A1 (en) * 2000-02-24 2001-09-03 Oxford Glycosciences (Uk) Limited Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (bad) and unipolar depression
WO2001073022A1 (fr) * 2000-03-29 2001-10-04 Kyowa Hakko Kogyo Co., Ltd. Gene associe a la glomerulonephrite proliferative
CA2429959A1 (fr) 2000-12-07 2002-06-13 Zymogenetics, Inc. Proteine associee au complement adipocyte zacrp3x2
EP1354950A4 (fr) * 2000-12-28 2005-01-12 Asahi Kasei Pharma Corp Gene d'activation de nf-kb
EP1397383A2 (fr) * 2001-06-20 2004-03-17 Genentech, Inc. Nouveau polypeptide secrete et methodes de traitement des troubles osseux
EP1513875A2 (fr) * 2002-05-10 2005-03-16 Serono Genetics Institute S.A. Polynucleotides et polypeptides krib et utilisations de ceux-ci dans le traitement de troubles metaboliques
WO2003102182A1 (fr) * 2002-05-31 2003-12-11 Hidetoshi Inoko Gene slurp-2 associe a une maladie de peau inflammatoire et utilisation de ce gene
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1790664A1 (fr) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
DK2069793T3 (en) 2006-08-29 2017-04-24 Oxford Biotherapeutics Ltd IDENTIFICATION OF PROTEIN IN CONNECTION WITH HEPATOCELLULAR CARCINOMA, GLIOBLASTOMA AND LUNG CANCER
EA028336B1 (ru) 2009-03-05 2017-11-30 МЕДАРЕКС Л.Л.Си. Полностью человеческие антитела, специфические в отношении cadm1
WO2013167153A1 (fr) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Anticorps utiles dans le diagnostic du cancer
KR101695792B1 (ko) * 2014-09-04 2017-01-12 디오셀 주식회사 신규 세포막 투과 펩티드 및 생리활성 물질 전달체로서의 그의 용도

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
JPH10508486A (ja) * 1994-11-07 1998-08-25 メルク エンド カンパニー インコーポレーテッド 修飾神経ペプチドｙレセプター
AU1532697A (en) * 1996-01-12 1997-08-01 Genetics Institute Inc. Beta-chemokine, h1305 (mcp-2)
ATE361933T1 (de) * 1997-08-01 2007-06-15 Serono Genetics Inst Sa 5' ests für sekretierte proteine aus gehirngeweben
EP1000148A2 (fr) * 1997-08-01 2000-05-17 Genset Marqueurs sequences 5' exprimes pour proteines secretees exprimees dans la prostate
WO1999031236A2 (fr) * 1997-12-17 1999-06-24 Genset ADNc PROLONGES POUR PROTEINES SECRETEES
CA2319089A1 (fr) * 1998-04-09 1999-10-21 Genset S.A. Etiquettes de sequences exprimees (est) des 5' et proteines humaines codees
CN1158386C (zh) * 1998-04-29 2004-07-21 吉尼西斯研究及发展有限公司 从皮肤细胞中分离的多核苷酸及其使用方法
JP2002532083A (ja) * 1998-12-17 2002-10-02 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４７個のヒト分泌タンパク質
CA2296792A1 (fr) * 1999-02-26 2000-08-26 Genset S.A. Sequences marqueurs exprimees et proteines humaines codees
JP2004507202A (ja) * 1999-03-31 2004-03-11 キュラジェン　コーポレイション ポリペプチドをコードするオープンリーディングフレームを含む核酸；「ｏｒｆｘ」
EP1194545A2 (fr) * 1999-06-23 2002-04-10 Curagen Corporation Polypeptides secretes et polynucleotides correspondants
EP1074617A3 (fr) * 1999-07-29 2004-04-21 Research Association for Biotechnology Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
CA2311201A1 (fr) * 1999-08-05 2001-02-05 Genset S.A. Sequences marqueurs exprimees et proteines humaines codees
DK1992695T3 (da) * 1999-08-12 2011-02-14 Agensys Inc Lectin-transmembran-antigen af type C udtrykt i human prostatacancer og avendelser deraf
WO2001012660A2 (fr) * 1999-08-17 2001-02-22 Sagami Chemical Research Center Proteines humaines a domaines hydrophobes et adn codant pour ces proteines
US6635742B1 (en) * 2000-01-25 2003-10-21 Nuvelo, Inc. Antibodies specific for semaphorin-like polypeptides

Also Published As

Publication number Publication date
EP1616878A1 (fr) 2006-01-18
JP2006115848A (ja) 2006-05-11
ATE417063T1 (de) 2008-12-15
DK1169442T3 (da) 2006-10-16
EP1169442B1 (fr) 2006-06-07
JP4174183B2 (ja) 2008-10-29
EP1688430B1 (fr) 2009-11-18
ATE409228T1 (de) 2008-10-15
ATE449108T1 (de) 2009-12-15
CA2361221A1 (fr) 2000-09-28
NZ527293A (en) 2005-01-28
JP2006136325A (ja) 2006-06-01
JP2006158392A (ja) 2006-06-22
JP2006101881A (ja) 2006-04-20
JP4392759B2 (ja) 2010-01-06
EP1609863B1 (fr) 2008-09-24
EP1609863A2 (fr) 2005-12-28
PT1169442E (pt) 2006-10-31
EP1616878B1 (fr) 2008-12-10
EP1688430A2 (fr) 2006-08-09
JP4402034B2 (ja) 2010-01-20
ES2314521T3 (es) 2009-03-16
EP1169442A2 (fr) 2002-01-09
JP2003527074A (ja) 2003-09-16
DK1616878T3 (da) 2009-03-30
PT1609863E (pt) 2009-01-02
NZ536320A (en) 2006-04-28
PT1616878E (pt) 2009-03-18
JP2006101880A (ja) 2006-04-20
WO2000056889A2 (fr) 2000-09-28
ATE329023T1 (de) 2006-06-15
NZ527292A (en) 2005-03-24
JP4392760B2 (ja) 2010-01-06
AU764092B2 (en) 2003-08-07
EP1688430A3 (fr) 2006-11-02
ES2319202T3 (es) 2009-05-05
JP2006115847A (ja) 2006-05-11
JP4398937B2 (ja) 2010-01-13
KR100504305B1 (ko) 2005-07-28
AU3864800A (en) 2000-10-09
WO2000056889A3 (fr) 2001-04-26
EP1609863A3 (fr) 2006-04-12
ES2269125T3 (es) 2007-04-01
KR20010112927A (ko) 2001-12-22
JP2010075189A (ja) 2010-04-08

Similar Documents

Publication Publication Date Title
ATE478145T1 (de) Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
ATE447583T1 (de) Polypeptide und dafür kodierende nukleinsäure
DK1609863T3 (da) Udskilte polypeptider og transmembranpolypeptider samt nucleinsyrer kodende for disse
DK1205546T3 (da) Polypeptider og nucleinsyrer kodende derfor
KR100515858B1 (en) PRO617 Polypeptides
DK1621619T3 (da) Secernerede polypeptider og transmembran-polypeptider og nukleinsyrer, der koder for disse
DK1251173T3 (da) Secernerede og transmembrane polypeptider og nucleinsyrer kodende for disse
DK1591452T3 (da) Secernerede og transmembrane polypeptider og nukleinsyrer kodende for samme
DE69926415D1 (de) Sekretiertes Polypeptide und dafür kodierende Nukleinsäuren
DK1300417T3 (da) Secerneret og transmembrant polypeptid og nucleinsyre kodende derfor
KR100515856B1 (en) PRO618 Polypeptides
KR100515855B1 (en) PRO351 Polypeptides
KR100514268B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
DK1217006T3 (da) Polypeptider og nucleinsyrer kodende for samme
DK1241180T3 (da) Humant A33 antigen-lignende protein og nucleinsyrer, der koder for dette
DK1191101T3 (da) PRO241 polypeptider og nucleinsyre kodende herfor
DK1241184T3 (da) Humant synaptogyrin-lignende protein og nukleinsyrer kodende for dette
DK1241183T3 (da) Humant HCAR-agtig protein og nucleinsyrer kodende derfor
DK1207168T3 (da) Polypeptider og nucleinsyrer kodende derfor
DK1205550T3 (da) Polypeptider og nucleinsyrer kodende derfor